BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 11121661)

  • 1. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical radiobiology of proton therapy: modeling of RBE.
    Jones B
    Acta Oncol; 2017 Nov; 56(11):1374-1378. PubMed ID: 28820311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of RBE effects using the concept of biologically effective dose.
    Dale RG; Jones B
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):639-45. PubMed ID: 10078651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments.
    Carabe-Fernandez A; Dale RG; Jones B
    Int J Radiat Biol; 2007 Jan; 83(1):27-39. PubMed ID: 17357437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.
    Wedenberg M; Lind BK; Hårdemark B
    Acta Oncol; 2013 Apr; 52(3):580-8. PubMed ID: 22909391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak.
    Marshall TI; Chaudhary P; Michaelidesová A; Vachelová J; Davídková M; Vondráček V; Schettino G; Prise KM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):70-77. PubMed ID: 27084630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness.
    Jones B; McMahon SJ; Prise KM
    Clin Oncol (R Coll Radiol); 2018 May; 30(5):285-292. PubMed ID: 29454504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of high-LET radiotherapy dose required for compensation of overall treatment time extensions.
    Jones B; Carabe-Fernandez A; Dale RG
    Br J Radiol; 2006 Mar; 79(939):254-7. PubMed ID: 16498040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative biological effectiveness (RBE) values for proton beam therapy.
    Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of variable RBE on proton fractionation.
    Dasu A; Toma-Dasu I
    Med Phys; 2013 Jan; 40(1):011705. PubMed ID: 23298075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
    Paganetti H
    Phys Med Biol; 2014 Nov; 59(22):R419-72. PubMed ID: 25361443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
    Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
    Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
    Zhou C; Jones B; Moustafa M; Yang B; Brons S; Cao L; Dai Y; Schwager C; Chen M; Jaekel O; Chen L; Debus J; Abdollahi A
    Clin Transl Radiat Oncol; 2019 Jan; 14():25-32. PubMed ID: 30511024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.